Vanda Pharmaceuticals (VNDA) Operating Margin (2016 - 2025)
Historic Operating Margin for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 55.61%.
- Vanda Pharmaceuticals' Operating Margin fell 325200.0% to 55.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.1%, marking a year-over-year decrease of 374600.0%. This contributed to the annual value of 20.46% for FY2024, which is 132100.0% down from last year.
- Per Vanda Pharmaceuticals' latest filing, its Operating Margin stood at 55.61% for Q3 2025, which was down 325200.0% from 73.21% recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Operating Margin high stood at 18.22% for Q2 2021, and its period low was 81.99% during Q1 2025.
- For the 5-year period, Vanda Pharmaceuticals' Operating Margin averaged around 13.43%, with its median value being 12.74% (2022).
- Per our database at Business Quant, Vanda Pharmaceuticals' Operating Margin soared by 167200bps in 2021 and then plummeted by -625300bps in 2025.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Operating Margin stood at 12.7% in 2021, then fell by -19bps to 10.28% in 2022, then crashed by -252bps to 15.67% in 2023, then dropped by -23bps to 19.33% in 2024, then crashed by -188bps to 55.61% in 2025.
- Its Operating Margin was 55.61% in Q3 2025, compared to 73.21% in Q2 2025 and 81.99% in Q1 2025.